View in EDS HTML Full Text PDF Full Text

Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.

Saved in:
Bibliographic Details
Title: Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Authors: Duchow A; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Bellmann-Strobl J; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Friede T; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany., Aktas O; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Angstwurm K; Department of Neurology, University of Regensburg, Regensburg, Germany., Ayzenberg I; Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany., Berthele A; Department of Neurology, School of Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Dawin E; Department of Neurology with Institute of translational Neurology, University of Münster, Münster, Germany., Engels D; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University Munich, Munich, Germany., Fischer K; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Flaskamp M; Department of Neurology, School of Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Giglhuber K; Department of Neurology, School of Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Grothe M; Department of Neurology, University of Greifswald, Greifswald, Germany., Havla J; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University Munich, Munich, Germany., Hümmert MW; Department of Neurology, Hannover Medical School, Hannover, Germany., Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany., Kaste M; Department of Neurology, Nordwest Hospital Sanderbusch, Sande, Germany., Kern P; Department of Neurology, Asklepios Expert Clinic Teupitz, Teupitz, Germany., Kleiter I; Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany., Klotz L; Department of Neurology with Institute of translational Neurology, University of Münster, Münster, Germany., Korporal-Kuhnke M; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany., Kraemer M; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Department of Neurology, Alfried Krupp Hospital, Essen, Germany., Krumbholz M; Department of Neurology and Pain Treatment, Multiple Sclerosis Center, Center for Translational Medicine, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.; Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.; Department of Neurology & Stroke, University Hospital of Tübingen, Tübingen, Germany., Kümpfel T; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University Munich, Munich, Germany., Lohmann L; Department of Neurology with Institute of translational Neurology, University of Münster, Münster, Germany., Ringelstein M; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Department of Neurology, Centre for Neurology and Neuropsychiatry, LVR-Klinikum, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Rommer P; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Department of Neurology, Rostock University Medical Center, Rostock, Germany., Schindler P; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Schubert C; Department of Neurology and Institute of Neuroimmunology and MS (INIMS), University Medical Center Hamburg -Eppendorf, Hamburg, Germany., Schwake C; Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany., Senel M; Department of Neurology, University of Ulm, Ulm, Germany., Then Bergh F; Department of Neurology, University of Leipzig, Leipzig, Germany., Tkachenko D; Department of Neurology, Hannover Medical School, Hannover, Germany., Tumani H; Department of Neurology, University of Ulm, Ulm, Germany., Trebst C; Department of Neurology, Hannover Medical School, Hannover, Germany., Vardakas I; Department of Neurology, University of Ulm, Ulm, Germany., Walter A; Department of Neurology, Herford Hospital, Herford, Germany., Warnke C; Department of Neurology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Göttingen, Germany., Weber MS; Institute of Neuropathology, Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.; Fraunhofer Institute for Translational Medicine and, Pharmacology, Göttingen, Jena, Germany., Wickel J; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Hamburg, Germany., Wildemann B; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany., Winkelmann A; Department of Neurology, Rostock University Medical Center, Rostock, Germany., Paul F; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Stellmann JP; Department of Neurology and Institute of Neuroimmunology and MS (INIMS), University Medical Center Hamburg -Eppendorf, Hamburg, Germany.; APHM, Hopital de la Timone, CEMEREM, Marseille, France.; Aix Marseille Univ, CNRS, CRMBM, Marseille, France., Häußler V; Department of Neurology and Institute of Neuroimmunology and MS (INIMS), University Medical Center Hamburg -Eppendorf, Hamburg, Germany.
Corporate Authors: Neuromyelitis Optica Study Group (NEMOS)
Source: Annals of neurology [Ann Neurol] 2024 Apr; Vol. 95 (4), pp. 720-732. Date of Electronic Publication: 2024 Jan 13.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1531-8249
DOI:10.1002/ana.26858